---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-24-005988"
form_type: "8-K"
ticker: "VNRX"
cik: "0000093314"
company_name: "VOLITIONRX LTD"
filed_at: "2024-09-27T23:59:59+00:00"
generated_at: "2026-05-31T01:23:05.937462+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# VolitionRx enters CEO employment agreement with Dr. Michel for Belgian subsidiary; consulting fee amended

## Summary
- Employment agreement with Dr. Gaetan Michel as CEO of Belgian Volition, effective Sept 1, 2024, with €12,000/month salary plus 13th month bonus.
- Consulting agreement amendment with 3F Management SRL increases monthly fee to €15,598 from Nov 1, 2024; variable bonus up to €26,390.
- Dr. Michel also serves as COO of parent, CEO of Volition America, and Manager of Volition Veterinary Diagnostics.
- Combined aggregate annual compensation is materially consistent with prior arrangements.

## SEC filing metadata
- accession: 0001477932-24-005988
- form_type: 8-K
- ticker: VNRX
- cik: 0000093314
- company_name: VOLITIONRX LTD
- filed_at: 2024-09-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/93314/000147793224005988/0001477932-24-005988-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/93314/000147793224005988/vnrx_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-24-005988
- JSON: https://secwatch.observer/filing/0001477932-24-005988.json
- Plain text: https://secwatch.observer/filing/0001477932-24-005988.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.